Business & Leadership

Baker McKenzie Makes a Life Sciences Play

The firm is building its healthcare & pharma practice on the East Coast

The firm is building its healthcare & pharma practice on the East Coast

Randall Sunberg, former co-chair of Morgan, Lewis & Bockius’s life sciences department, left for Baker McKenzie this week; he was joined by corporate and securities expert Denis Segota. Though technically belonging to the firm’s New York office, both partners will be working in Princeton, New Jersey – a state that employs over 117,000 people in the life sciences industry.


Life sciences contribute $47.5bn to New Jersey’s economy every year; indeed, the Garden State is home to the key operation facilities of 12 of the world’s top 20 biopharmaceutical companies. The sector is spanned comprehensively in the area, from drugs and pharmaceuticals to medical devices to distribution, and so it makes sense for law firms making healthcare and life sciences plays to strengthen their base there, as well as in the so-called “life sciences corridor” in Massachusetts. Indeed, we covered this trend here last month.


Sunberg, who will be co-heading Baker McKenzie’s North America life sciences department, has longstanding expertise in assisting a range of clients in the sector with commercial and financing matters. Sunberg and M&A and financing expert Segota both cited their new firm’s expertise in emerging markets as a key reason for their move. “Our pharmaceutical clients are focusing on growth and they’re looking at emerging markets for [that] growth,” said Segota.


Another reason was Baker McKenzie’s industry focus. The firm fields hundreds of lawyers around the world who advise healthcare, biotech and pharmaceuticals companies on the full range of legal matters, and while it may not rank among the very top healthcare & life sciences dealmakers in the US by volume or value, its global platform, strength in depth and breadth of service within the healthcare and life sciences sector are undeniable.

Read the full Special Report: USA: Global Powerhouse

It is the best of times, it is the worst of times. In a world where the only thing that doesn't change is change itself, opportunities and risks are too obvious to ignore, and the legal market is no exception. As a nearly $300 billion industry and one of the most profitable in the world, the U.S. legal industry is under fundamental transformation. Whether in-house counsel or law firms, only those with far-ranging sights, clear thoughts and quick action can survive and thrive.
Summary The IPO Annual Meeting: An IP event not to miss Merger master Wachtell scores impressive double-whammy Eversheds Sutherland Opens a Chicago Office HFW Hires Additional Energy Partner Interview with Manny Schecter, IBM's Chief Patent Counsel Interview with Brian Fahey, CEO at MyComplianceOffice Analysis: Exodus From Proskauer as Kirkland Makes Big Hires Power move: Sidley Austin hires Orrick energy partners The Rise of Litigation Funders in the USA Interview: Jason Parkman, CEO, Mitratech


Accenture's CEO and CFO interview by Leaders League Group

About us